[ Price : $8.95]
FDA warns Brea, CA-based Clinical Resources Laboratory about CGMP violations in its production of misbranded unapproved new drugs.[ Price : $8.95]
Attorney Bryan Feldhaus says the revised FDA intended use regulation clarifies but does not change the definition of intended use ...[ Price : $8.95]
FDA warns San Diego, CA-based Vitae Enim Vitae Scientific about repeat CGMP violations in its work producing finished drugs as a c...[ Price : $8.95]
The House Select Subcommittee on the Coronavirus Crisis is asking for an FDA briefing on the status of vaccination for children un...[ Price : $8.95]
Wilson and Sontini attorneys say the Department of Justice Consumer Protection Bureau featured FDA in its recent highlights report...[ Price : $8.95]
Federal Register notice: FDA withdraws the approval of 14 no-longer-marketed ANDAs from multiple applicants.[ Price : $8.95]
Federal Register notice: As part of FDAs ongoing Drug Efficacy Study Implementation, the agency announces that all outstanding hea...[ Price : $8.95]
Student advocates from Universities Allied for Essential Medicines ask to meet with FDA commissioner Robert Califf on ways to impr...